Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Sales 2020 | 304M 325M 27.1B | Sales 2021 | 328M 351M 29.26B | Capitalization | 724M 774M 64.57B |
---|---|---|---|---|---|
Net income 2020 | 33M 35.28M 2.94B | Net income 2021 | 60M 64.15M 5.35B | EV / Sales 2020 | 3.16 x |
Net Debt 2020 | 237M 254M 21.16B | Net Debt 2021 | 249M 266M 22.21B | EV / Sales 2021 | 2.97 x |
P/E ratio 2020 |
21.5
x | P/E ratio 2021 |
11.9
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Amer Jaber
COO | Chief Operating Officer | - | 01/19/01 |
Daniel Smith
CTO | Chief Tech/Sci/R&D Officer | - | 11/16/11 |
Nicola Lamacchia
BRD | Director/Board Member | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nunzio Antonelli
BRD | Director/Board Member | - | 10/15/10 |
Nicola Lamacchia
BRD | Director/Board Member | - | 01/17/01 |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- STAGR Stock